ACE inhibitor and beta-blocker combination

This page covers all ACE inhibitor and beta-blocker combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting ACE (angiotensin-converting enzyme) and beta-adrenergic receptors.

Targets

ACE (angiotensin-converting enzyme) and beta-adrenergic receptors

Phase 3 pipeline (1)

• Enalapril and carvedilol · Hospital Clinic of Barcelona · Cardiovascular
  This combination reduces blood pressure and heart workload by blocking angiotensin II formation (enalapril) and beta-adrenergic signaling (carvedilol).

Patent intelligence

• ace inhibitor and beta blocker combination patent landscape — aggregated cliff calendar, attackable patents, originator estates